Antibiotic consideration in bacterial vaginosis
- First Online:
Bacterial vaginosis (BV) is a syndrome characterized by the loss of indigenous vaginal lactobacilli and massive polymicrobial anaerobic vaginal overgrowth of elusive etiology. Although progress has occurred in defining the composition of the vaginal microbiome using DNA amplifications, rapidly accumulating data have not resulted in therapeutic advantage. Treatment options remain limited and outcome often unsatisfactory, particularly regarding the frequent recurrence of symptomatic disease, leading to enormous frustration among patients and practitioners. This review does not address the important issues of transmission, diagnosis, and complications of BV, but focuses on antimicrobial activity of current drugs and their limitations in vitro and in vivo. Recognizing these limitations should allow for either development of new antibiotics or for innovative use of currently available drugs in new study protocols.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 4.Ferris MJ, Masztal A, Aldridge KE, et al.: Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis. BMC Infect Dis 2004, 13:4–5.Google Scholar
- 8.Centers for Disease Control and Prevention, Workowski KA, Berman SM: Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006, 55(RR-11):1–94.Google Scholar
- 9.Oduyebo OO, Anorlu RI, Ogunsola FT: The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev 2009, 8:CD006055.Google Scholar
- 13.Senok A, Verstraebrn H, Temmerman M, Botta G: Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev 2006, 4:CD006289.Google Scholar
- 25.De Backer E, Dubreuil L, Brauman M, et al.: In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis. Clin Microbiol Infect 2009 (Epub ahead of print).Google Scholar
- 36.Reichman O, Akins R, Sobel JD: Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis. Sex Transm Dis 2009 (Epub ahead of print).Google Scholar